ASR Dutch Science Park Fund acquires Beijerinck Center and Van Iterson House from dsm-firmenich

Effective from 1 July, a.s.r. real estate has acquired the Beijerinck Center and the Van Iterson House from dsm-firmenich on behalf of the ASR Dutch Science Park Fund. These multi-tenant buildings at the Biotech Campus Delft house biotechnology start-ups and scale-ups and offer shared facilities such as a restaurant, gym and meeting rooms. Planet B.io is building the ecosystem and community at Biotech Campus Delft on behalf of the ASR Dutch Science Park Fund, supporting the fund in developing the campus and acquiring new tenants.

Over a year ago, ASR Dutch Science Park Fund and dsm-firmenich agreed on a long-term collaboration to further develop the Biotech Campus Delft into a global leader in bioscience. As a first step, the fund invested in the acquisition of the new global headquarters and application laboratories of dsm-firmenich’s business unit Taste, Texture and Health. On 1 July, the Beijerinck Center and the Van Iterson House were added to the fund portfolio.

Biotech Campus Delft takes on green and sustainable features
The ASR Dutch Science Park Fund and dsm-firmenich have developed a plan on how the campus is going to be designed. The aim is to achieve 100,000 m² of lettable floor space by 2040. The campus will be landscaped with lots of greenery and attention to biodiversity and water collection. Cyclists and pedestrians will be given priority over cars. This will make the campus a pleasant, attractive green place to visit and encourage people meeting and collaborating with one another in various ways. Moreover, the sustainable design matches the campus’s focus on sustainable biotechnology.

Planet B.io creates a unique and inspiring ecosystem
The non-profit organisation Planet B.io is creating a unique and inspiring ecosystem at the Biotech Campus Delft, where biotechnology companies will be eager to locate. Through cooperation and access to the necessary knowledge and infrastructure, these companies can develop and grow faster. Besides local activities, Planet B.io also offers a large network of public and private organisations supporting the biotech sector. Planet B.io is the exclusive partner of ASR Dutch Science Park Fund to further expand the ecosystem on campus in the coming years with attractive large and small biotech companies from the Netherlands and other countries.

More about the ASR Dutch Science Park Fund
The ASR Dutch Science Park Fund invests in commercial real estate on science parks in the Netherlands. In doing so, the fund actively contributes to the development of the Dutch knowledge sector. Investing in commercial property in the local ecosystem of science parks, allows companies to be physically closer to new technology and knowledge. This promotes the development of new knowledge into products and services that benefit society. The ASR Dutch Science Park Fund targets institutional investors. ASR Nederland N.V. is anchor investor.

More about Biotech Campus Delft
Biotech Campus Delft is Europe's largest open innovation campus focused on biotechnology that boosts the transition to a sustainable, biobased economy. The entire innovation cycle is supported, from research to pilot to production. The campus hosts multiple companies: start-ups, scale-ups, established companies and knowledge institutions, all contributing to the transition in their own way. Together, we foster open innovation, while providing the resources and competences needed to innovate and grow.

More about dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people. 

www.dsm-firmenich.com